These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21261589)

  • 1. The role of corticotropin-releasing hormone in the pathophysiology of depression: therapeutic implications.
    Lloyd RB; Nemeroff CB
    Curr Top Med Chem; 2011; 11(6):609-17. PubMed ID: 21261589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of corticotropin-releasing factor in depression and anxiety disorders.
    Arborelius L; Owens MJ; Plotsky PM; Nemeroff CB
    J Endocrinol; 1999 Jan; 160(1):1-12. PubMed ID: 9854171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease.
    Naughton M; Dinan TG; Scott LV
    Handb Clin Neurol; 2014; 124():69-91. PubMed ID: 25248580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The organization of the stress system and its dysregulation in depressive illness.
    Gold PW
    Mol Psychiatry; 2015 Feb; 20(1):32-47. PubMed ID: 25486982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agarwood Essential Oil Ameliorates Restrain Stress-Induced Anxiety and Depression by Inhibiting HPA Axis Hyperactivity.
    Wang S; Wang C; Yu Z; Wu C; Peng D; Liu X; Liu Y; Yang Y; Guo P; Wei J
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response.
    Dedic N; Chen A; Deussing JM
    Curr Mol Pharmacol; 2018; 11(1):4-31. PubMed ID: 28260504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
    Scott LV; Dinan TG
    Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress.
    Makino S; Hashimoto K; Gold PW
    Pharmacol Biochem Behav; 2002 Aug; 73(1):147-58. PubMed ID: 12076734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies.
    Owens MJ; Nemeroff CB
    Ciba Found Symp; 1993; 172():296-308; discussion 308-16. PubMed ID: 8491091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
    Juruena MF; Bocharova M; Agustini B; Young AH
    J Affect Disord; 2018 Jun; 233():45-67. PubMed ID: 29150144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic all-trans retinoic acid administration induces CRF over-expression accompanied by AVP up-regulation and multiple CRF-controlling receptors disturbance in the hypothalamus of rats.
    Cai L; Li R; Zhou JN
    Brain Res; 2015 Mar; 1601():1-7. PubMed ID: 25578258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain.
    Owens MJ; Bissette G; Nemeroff CB
    Synapse; 1989; 4(3):196-202. PubMed ID: 2575286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R; Anconetani B; Chattat R; Biscotti M; Spinucci G; Casimirri F; Vicennati V; Carcello A; Labate AM
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hypothalamic corticotropin-releasing factor in mediating alcohol-induced activation of the rat hypothalamic-pituitary-adrenal axis.
    Rivier C
    Front Neuroendocrinol; 2014 Apr; 35(2):221-33. PubMed ID: 24211830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal stress programs neuroendocrine stress responses and affective behaviors in second generation rats in a sex-dependent manner.
    Grundwald NJ; Brunton PJ
    Psychoneuroendocrinology; 2015 Dec; 62():204-16. PubMed ID: 26318631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The corticotropin-releasing factor (CRF) family of peptides as local modulators of adrenal function.
    Tsatsanis C; Dermitzaki E; Venihaki M; Chatzaki E; Minas V; Gravanis A; Margioris AN
    Cell Mol Life Sci; 2007 Jul; 64(13):1638-55. PubMed ID: 17453142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the corticotropin-releasing hormone (CRH) neurocircuitry: Insights into post stroke functional impairments.
    Barra de la Tremblaye P; Plamondon H
    Front Neuroendocrinol; 2016 Jul; 42():53-75. PubMed ID: 27455847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Don't stress about CRF: assessing the translational failures of CRF
    Spierling SR; Zorrilla EP
    Psychopharmacology (Berl); 2017 May; 234(9-10):1467-1481. PubMed ID: 28265716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders.
    Bravo JA; Dinan TG; Cryan JF
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):666-83. PubMed ID: 20860876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.